Weighted Average Number of Shares Outstanding, Basic of Nabriva Therapeutics plc from 2014 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nabriva Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2014 to Q2 2023.
  • Nabriva Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2023 was 3.23M shares, a 27.7% increase year-over-year.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.68M shares, a 54.7% increase from 2021.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.73M shares, a 237% increase from 2020.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 514K shares, a 93.1% decline from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 3.23M +701K +27.7% 01 Apr 2023 30 Jun 2023 10-Q 19 Oct 2023
Q1 2023 3.2M +850K +36.1% 01 Jan 2023 31 Mar 2023 10-Q 22 May 2023
Q4 2022 2.68M +948K +54.7% 01 Oct 2022 31 Dec 2022 10-K 17 Apr 2023
Q3 2022 2.73M +712K +35.2% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 2.53M -38M -93.8% 01 Apr 2022 30 Jun 2022 10-Q 19 Oct 2023
Q1 2022 2.35M -24.1M -91.1% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 1.73M 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 2.02M -12.4M -86% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 40.6M +29.3M +260% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 26.4M 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q3 2020 14.5M 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 11.3M 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q2 2017 27.2M +5.93M +27.9% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 2.72M +603K +28.4% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017
Q2 2016 21.3M 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 2.12M 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017

Nabriva Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 2.68M +948K +54.7% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 1.73M +1.22M +237% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 514K -6.91M -93.1% 01 Jan 2020 31 Dec 2020 10-K 17 Apr 2023
2019 7.42M 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022
2016 2.15M +1.09M +103% 01 Jan 2016 31 Dec 2016 10-K 24 Mar 2017
2015 1.06M +734K +226% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 325K 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.